As winter settles over Australia, it's not just the drop in temperature we notice—there's also a sharp rise in respiratory ...

MPV tends to hit hardest in young children, older adults and people with weakened immune systems. A virologist explains.

Meanwhile, Sanofi has pointed to Beyfortus’ 75% reduction in the incidence of MALRI versus Enflosia’s figure of 60%. The ...

An ear infection can present as a dull, persistent ache, and is sometimes accompanied by pressure, discharge, itching, fever or muffled hearing. In more severe cases, the pain can be sudden, sharp and ...

MSD has received FDA approval for Enflonsia (clesrovimab-cfor) to prevent respiratory syncytial virus (RSV) in neonates and ...

One day before the potential FDA approval of a rival respiratory syncytial virus (RSV) monoclonal antibody from Merck & Co., ...

A substantial burden of hospitalizations for PIV-associated ARI was observed among pediatric patients in the United States.

A single dose of the long-acting antibody nirsevimab developed to prevent respiratory syncytial virus infections (The drug ...

India’s Ministry of Health has released new guidelines to help identify respiratory viral illness symptoms. Early recognition ...

The strain of bird flu that infected a Michigan dairy worker in May 2024 is capable of airborne transmission, according to ...

At least 62 people with measles have traveled on planes this year, and one person became infected. But being fully vaccinated ...

A single dose of the long-acting antibody nirsevimab to infants can halve hospitalizations for bronchiolitis.